Stock Updates

How has Teva Pharmaceutical Industries Limited:(NYSE:TEVA) performed recently?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 49790.39. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 28.16, a forward P/E of 9.06 and EPS of 1.92. At a stock price of 53.89 (-0.40%) it has a dividend yield of 2.51%.

EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 12.90% and more long-term 5.22% after five years. EPS growth quarter over quarter is 19.10%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is -3.50%.

For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of 6.22%. For the last month performance for Teva Pharmaceutical Industries Limited is 3.62%. While the last quarter is -0.96% and half year, -12.37%. Finally for the year, performance is -12.87%.

The 52-week high for Teva Pharmaceutical Industries Limited, is at -23.71%, and for the 52-week low it comes to a value of 12.24%. The 20-day simple moving average is 3.97% and -5.50% for the 200-day simple moving average.

Volatility for the week is at 2.77%, and for the month it is 2.10%. Teva Pharmaceutical Industries Limited, has a target price of 71.68.

In terms of debt, long term debt/equity is 0.28, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.34. The gross margin is 58.10%, while operating margin is 19.30%, the profit margin is 8.70%. The current ratio is 1.3 and the quick ratio is 1.

Insider ownership is at 2.70%, with instituitional ownership at 67.00%. Teva Pharmaceutical Industries Limited has a payout ratio of 70.10%. With the total shares outstanding coming to 920.34. The shares float is 914.06, with the float short at 2.18%, with short ratio coming to 3.14.

In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 3.30%, with its returns on investment at 5.70%. Return on equity is 6.60%. So will the investors see the target price of 71.68, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Stephen Butters

Leave a Comment